Regenerative Medicine Minnesota (RMM) has awarded 13 grants totalling $4.3 million to support discovery, development, translation and commercialization of regenerative medicine-based innovations to improve human health in Minnesota and beyond. The award-winning projects and awardees for 2024 are: Clinical Trial Award: Phase 1 Study of Intravenous Administration of Adeno-Associated Virus Gene Therapy for Individuals with Propionic Acidemia Michael Barry, Ph.D., Mayo Clinic Propionic acidemia (PA) is a severe metabolic disorder caused by mutations in the…
You may also like
Health & Wellness
Mayo Clinic Q and A: My mom has Alzheimer’s. What does that mean for me?
Editor’s Note: September is World Alzheimer’s Month DEAR MAYO CLINIC: I am part of what I hear called the Sandwich
Health & Wellness
Mayo Clinic Minute: Palliative medicine for cancer patients
Patients undergoing cancer treatments often use palliative medicine to cope with nausea, fatigue and other bothersome symptoms. Palliative medicine is